Abstract

Recently, a novel 87-amino acid influenza A virus protein with proapoptotic properties, PB1-F2, has been reported that originates from an alternative reading frame in the PB1 polymerase gene and is encoded in most known human influenza A virus isolates. Here we characterize the molecular structure of a biologically active synthetic version of the protein (sPB1-F2). Western blot analysis, chemical cross-linking, and NMR spectroscopy afforded direct evidence of the inherent tendency of sPB1-F2 to undergo oligomerization mediated by two distinct domains located in the N and C termini, respectively. CD and (1)H NMR spectroscopic analyses indicate that the stability of structured regions in the molecule clearly depends upon the hydrophobicity of the solvent. In aqueous solutions, the behavior of sPB1-F2 is typical of a largely random coil peptide that, however, adopts alpha-helical structure upon the addition of membrane mimetics. (1)H NMR analysis of three overlapping peptides afforded, for the first time, direct experimental evidence of the presence of a C-terminal region with strong alpha-helical propensity comprising amino acid residues Ile(55)-Lys(85) connected via an essentially random coil structure to a much weaker helix-like region, located in the N terminus between residues Trp(9) and Lys(20). The C-terminal helix is not a true amphipathic helix and is more compact than previously predicted. It corresponds to a positively charged region previously shown to include the mitochondrial targeting sequence of PB1-F2. The consequences of the strong oligomerization and helical propensities of the molecule are discussed and used to formulate a hypothetical model of its interaction with the mitochondrial membrane.

Highlights

  • The genome of Influenza A virus (IAV), a representative of the orthomyxoviruses, consists of eight separate linear segments of negative sense RNA and was thought to encode 10 gene products

  • With the goal of understanding the molecular mechanism involved in the biological function of the regulatory IAV protein PB1-F2, we describe here the first structural characterization of the molecule derived from the IAVPR8 isolate

  • The sequence of the sPB1-F2 molecule used in the present investigation corresponds to the strain IAVPR8 (4, 11)

Read more

Summary

EXPERIMENTAL PROCEDURES

Peptide Synthesis and Purification—The synthesis, purification, and molecular characterization of sPB1-F2 and the three related fragments PB-(1– 40), PB-(30 –70), and PB-(50 – 87) derived from influenza A virus strain A/Puerto Rico/8/34(H1N1) (isolate IAVPR8) (4) are described in detail elsewhere (11). CD Spectroscopy—CD spectra of the protein and related peptides were recorded at room temperature and a concentration of 0.2 mg/ml in 0.5-mm cuvettes on a Jasco J-810 spectropolarimeter in a wavelength range from 260 to 180 nm at various TFE concentrations as described previously (8). Final structures were displayed and manipulated on an Silicon Graphics OCTANE-work station using the program BRAGI (16). After 30 min, the cross-linking reaction was terminated by the addition of glycine and 10 ␮l of SDS sample buffer (2% SDS, 1% ␤-mercaptoethanol, 10% glycerol in 65 mM Tris/HCl, pH 6.8). To follow the oligomerization of sPB1-F2 by Coomassie staining, the peptide was incubated at room temperature in PBS to a final protein concentration of 250 ␮g/ml. After Coomassie staining (0.5% Coomassie Brilliant Blue G-250, 10% acetic acid, 25% isopropyl alcohol), the gel was destained (25% methanol, 10% acetic acid), and processed for imaging

RESULTS
TFE and even more pronounced at
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call